arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CVRx, Inc.

CVRX
$5.93 ▲ +0.34 (+6.17%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

CVRx, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $154.7M
Dividend Yield
Revenue Growth 10.4%
Op. Margin -90.5%
ROIC -57.7%
FCF / Share $-1.56
Trailing P/E
Price / Book 4.0x
FCF Yield
Debt / Equity 1.26
info Valuation on last close. End-of-day price, Aug 6, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$56.65M
↑ +10.4%
Net Income Profit after all expenses
$-53.31M
↑ +11.1%
Operating Margin Operating profit as % of sales
-90.5%
↑ +22.0% 3th
FCF / Share Free cash flow per share
$-1.56
↑ +12.8%
Long-Term Debt Long-term obligations
$49.51M
— +0.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
6
Financial Health
26
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters